On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
Coca Cola will now reclassify its financial statements from second quarter in 2019 to include CCBA as part of its continuing operations. It did not provide an explanation for the postponement of its re-franchising plans. In a development that marks… Read More ›
This marks AB InBev’s final disinvestment following its acquisition of SABMiller. Subject to regulatory approvals, this deal is set to close by the end of 2017. In a development that underscores AB In-Bev’s push to consolidate its acquisition of SABMiller,… Read More ›
manageria.biz 